Published in Prog Clin Biol Res on January 01, 1985
Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects. Nucleic Acids Res (2001) 12.92
Improving lycopene production in Escherichia coli by engineering metabolic control. Nat Biotechnol (2000) 2.53
Activities and cellular localization of yeast proteases and their inhibitors. Biochem Biophys Res Commun (1974) 2.44
Gene expression profiling by DNA microarrays and metabolic fluxes in Escherichia coli. Biotechnol Prog (2000) 2.42
Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am J Physiol (1998) 2.20
DNA microarray detection of metabolic responses to protein overproduction in Escherichia coli. Metab Eng (2000) 1.91
Effective diffusion distance of nitric oxide in the microcirculation. Am J Physiol (1998) 1.83
Metabolic engineering of Escherichia coli for 1-butanol and 1-propanol production via the keto-acid pathways. Metab Eng (2008) 1.77
Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem (2000) 1.70
Arginase modulates nitric oxide production in activated macrophages. Am J Physiol (1998) 1.63
Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res (2001) 1.62
Engineering of Escherichia coli central metabolism for aromatic metabolite production with near theoretical yield. Appl Environ Microbiol (1994) 1.57
Enhanced production of succinic acid by overexpression of phosphoenolpyruvate carboxylase in Escherichia coli. Appl Environ Microbiol (1996) 1.56
Stimulation of glucose catabolism in Escherichia coli by a potential futile cycle. J Bacteriol (1992) 1.47
Alteration of growth yield by overexpression of phosphoenolpyruvate carboxylase and phosphoenolpyruvate carboxykinase in Escherichia coli. Appl Environ Microbiol (1993) 1.46
Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci U S A (2001) 1.45
Precursor balancing for metabolic engineering of lycopene production in Escherichia coli. Biotechnol Prog (2001) 1.45
Control of gluconeogenic growth by pps and pck in Escherichia coli. J Bacteriol (1993) 1.43
Isolation of a cDNA encoding a UV-damaged DNA binding factor defective in xeroderma pigmentosum group E cells. Mutat Res (1996) 1.42
Reduction of aerobic acetate production by Escherichia coli. Appl Environ Microbiol (1997) 1.41
Engineered synthetic pathway for isopropanol production in Escherichia coli. Appl Environ Microbiol (2007) 1.35
Children with mucopolysaccharidosis: perioperative care, morbidity, mortality, and new findings. J Pediatr Surg (1993) 1.30
Erythrocyte consumption of nitric oxide: competition experiment and model analysis. Nitric Oxide (2001) 1.27
Engineered isoprenoid pathway enhances astaxanthin production in Escherichia coli. Biotechnol Bioeng (1999) 1.26
Metabolic responses to substrate futile cycling in Escherichia coli. J Biol Chem (1994) 1.25
Pathway engineering for production of aromatics in Escherichia coli: Confirmation of stoichiometric analysis by independent modulation of AroG, TktA, and Pps activities. Biotechnol Bioeng (1995) 1.20
Determination of Flux Control Coefficients from transient metabolite concentrations. Biochem J (1992) 1.18
Neonatal circumcision. Pediatr Clin North Am (2001) 1.12
Spatial specificity of chromophore assisted laser inactivation of protein function. Biophys J (1992) 1.11
Purification and properties of two proteinases from Saccharomyces cerevisiae. Arch Biochem Biophys (1967) 1.09
Three yeast proteins that specifically inhibit yeast proteases A, B, and C. J Bacteriol (1975) 1.08
Directed evolution of metabolically engineered Escherichia coli for carotenoid production. Biotechnol Prog (2000) 1.08
Metabolic engineering of isoprenoids. Metab Eng (2001) 1.05
Metabolic control analysis using transient metabolite concentrations. Determination of metabolite concentration control coefficients. Biochem J (1992) 1.04
Thermostable endogenous inhibitors of cathepsins B and H. Eur J Biochem (1979) 1.03
oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles. Am J Physiol Heart Circ Physiol (2000) 1.02
Inverse flux analysis for reduction of acetate excretion in Escherichia coli. Biotechnol Prog (1997) 1.01
Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release. Fed Proc (1972) 1.00
Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Oncogene (2012) 0.97
Yeast proteinase B: identification of the inactive form as an enzyme-inhibitor complex. Arch Biochem Biophys (1969) 0.94
Metabolic engineering and control analysis for production of aromatics: Role of transaldolase. Biotechnol Bioeng (1997) 0.93
Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Commun (1996) 0.92
Alteration of product specificity of Rhodobacter sphaeroides phytoene desaturase by directed evolution. J Biol Chem (2001) 0.92
Effects of pharmacologic alterations of adrenergic mechanisms by cocaine, tropolone, aminophylline, and ketamine on epinephrine-induced arrhythmias during halothane-nitrous oxide anesthesia. Anesthesiology (1977) 0.90
Red blood cell sorbitol lowering effects and tolerance of single doses of AL 1576 (HOE 843) in diabetic patients. J Clin Pharmacol (1988) 0.90
Inhibitors associated with the proteinases of mammalian cells and tissues. Curr Top Cell Regul (1980) 0.90
Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium. Clin Chim Acta (1982) 0.89
Control of metabolic pathways by time-scale separation. Biosystems (1995) 0.89
Molecular weight studies on the active constituents of compound 48-80. J Med Chem (1972) 0.89
Cathepsins J and K: high molecular weight cysteine proteinases from human tissues. Biochem Biophys Res Commun (1984) 0.88
Reversed phase high performance liquid chromatographic separations of nucleotides in the presence of solvophobic ions. Anal Chem (1977) 0.88
Effects of ultraviolet light irradiation in biotreatment of organophosphates. Appl Biochem Biotechnol (1996) 0.85
Microbial pathway engineering for industrial processes: evolution, combinatorial biosynthesis and rational design. Curr Opin Microbiol (2001) 0.85
Purification and properties of human serum carnosinase. Clin Chim Acta (1991) 0.85
Rapid detection of urinary tract infections using isotachophoresis and molecular beacons. Anal Chem (2011) 0.85
Incorporating qualitative knowledge in enzyme kinetic models using fuzzy logic. Biotechnol Bioeng (1999) 0.85
Lipopolysaccharide activates endothelial nitric oxide synthase through protein tyrosine kinase. Biochem Biophys Res Commun (1998) 0.84
Transcriptional regulation and metabolism. Biochem Soc Trans (2005) 0.83
Effectiveness of preoperative sedation with rectal midazolam, ketamine, or their combination in young children. Anesth Analg (1992) 0.83
Effect of phenoxybenzamine and combined administration of iproniazid and tropolone on catecholamine release elicited by renal sympathetic nerve stimulation. J Pharmacol Exp Ther (1971) 0.83
Heterologous protein expression affects the death kinetics of baculovirus-infected insect cell cultures: a quantitative study by use of n-target theory. Biotechnol Prog (1994) 0.82
Homocarnosinosis: lack of serum carnosinase is the defect probably responsible for elevated brain and CSF homocarnosine. Clin Chim Acta (1983) 0.82
Characterization of human tissue carnosinase. Biochem J (1985) 0.81
High-performance liquid chromatography of pyruvic and alpha-ketoglutaric acids and its application to urine samples. Clin Chem (1977) 0.81
The efficacy of retinoic acid ointment for treatment of xerophthalmia and corneal epithelial wounds. Curr Eye Res (1985) 0.81
Pelvi-ureteric junction obstruction treated with Acucise retrograde endopyelotomy. Br J Urol (1998) 0.81
The distribution of carnosine and related dipeptides in rat and human tissues. Inflamm Res (1996) 0.80
Experimental determination of flux control distribution in biochemical systems: in vitro model to analyze transient metabolite concentrations. Biotechnol Bioeng (1993) 0.80
Acetate-inducible protein overexpression from the glnAp2 promoter of Escherichia coli. Biotechnol Bioeng (2001) 0.79
Homocarnosinase: a hog kidney dipeptidase with a broader specificity than carnosinase. Arch Biochem Biophys (1977) 0.79
Localization of a novel pathway for the liberation of GABA in the human CNS. Brain Res Bull (1994) 0.79
Specificity and distribution of mammalian carnosinase. Biochim Biophys Acta (1976) 0.78
Low molecular weight inhibitors of cathepsins B, H and T in human serum, synovial fluid and CSF. Biochem Biophys Res Commun (1982) 0.78
A histamine liberator in the tannin fraction of the Eucalypts. Lloydia (1970) 0.78
Antimicrobial action of compound 48/80 against protozoa, bacteria, and fungi. J Pharm Sci (1977) 0.78
Inborn errors of carnosine and homocarnosine metabolism. J Neural Transm Suppl (1990) 0.78
Management of odontogenic orbital cellulitis. J Med Life (2011) 0.77
Bestatin inhibition of human tissue carnosinase, a non-specific cytosolic dipeptidase. Biol Chem Hoppe Seyler (1988) 0.77
Alpha-N-acetyl-L-histidine amidohydrolase activity from the brain of the skipjack tuna Katsuwonus pelamis. Can J Biochem (1967) 0.77
A synthetic iterative pathway for ketoacid elongation. Methods Enzymol (2011) 0.76
A mutant phosphoenolpyruvate carboxykinase in Escherichia coli conferring oxaloacetate decarboxylase activity. J Bacteriol (1995) 0.75
Extraction and determination of chloroform in rat blood and tissues by gas chromatography-electron-capture detection: distribution of chloroform in the animal body. Clin Chem (1980) 0.75
Respiratory failure in newborns, infants and children. Indian J Pediatr (1981) 0.75
Dissimilarities between droperidol and phentolamine on vascular tone and dopamine and norepinephrine vasoconstriction. Res Commun Chem Pathol Pharmacol (1982) 0.75
Homocarnosinosis patients and great apes have a serum protein that cross-reacts with human serum carnosinase. Clin Chim Acta (1992) 0.75
High pressure liquid chromatography of p-methoxyanilides of fatty acids. Anal Chem (1976) 0.75
Serum carnosinase in blood and homocarnosine in CSF of patients with Følling's disease (PKU). J Oslo City Hosp (1987) 0.75
Carnosinase and homocarnosinosis. J Oslo City Hosp (1985) 0.75
Improved stability of methanolic wright's stain with additive reagents. Stain Technol (1981) 0.75
Rflex vasodilatation in the cat and dog anesthetized with ketamine. Proc Soc Exp Biol Med (1973) 0.75
Response to sympathetic stimulation during angiotensin tachyphylaxis in dog's paw. Arch Int Pharmacodyn Ther (1972) 0.75
Uptake of 14C-angiotensin by canine cutaneous blood vessels. Blood Vessels (1975) 0.75
Effect of angiotensin on uptake of 3 H-norepinephrine in dog cutaneous arteries. Proc Soc Exp Biol Med (1972) 0.75
Colorimetric determination of a polymeric quaternary ammonium antimicrobial preservative in an ophthalmic solution. J Assoc Off Anal Chem (1988) 0.75
A hybrid approach to modeling metabolic systems using a genetic algorithm and simplex method. IEEE Trans Syst Man Cybern B Cybern (1998) 0.75
Improved stability of methanolic Wright's stain solution with dual additives. Stain Technol (1982) 0.75
Anesthetic management of infants receiving an adult kidney transplant. Anesth Analg (1991) 0.75
Adrenergic responses in canine cutaneous vasculature during acute hemorrhagic hypotension. Am J Physiol (1975) 0.75